Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125285181 | 12528518 | 1 | I | 20160105 | 20160705 | 20160705 | EXP | US-PFIZER INC-3132164 | PFIZER | 53.00 | YR | M | Y | 0.00000 | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125285181 | 12528518 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | U | 11719 | ||||||||||
| 125285181 | 12528518 | 2 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | 71484 | ||||||||||
| 125285181 | 12528518 | 3 | SS | PEG/L-ASPARAGINASE | PEGASPARGASE | 1 | UNK | U | 0 | ||||||||||
| 125285181 | 12528518 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 125285181 | 12528518 | 5 | C | BLINATUMOMAB | BLINATUMOMAB | 1 | FOUR CYCLES | 0 | |||||||||||
| 125285181 | 12528518 | 6 | C | CYTARABINE. | CYTARABINE | 1 | UNK | 0 | |||||||||||
| 125285181 | 12528518 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 125285181 | 12528518 | 8 | C | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | 0 | |||||||||||
| 125285181 | 12528518 | 9 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125285181 | 12528518 | 1 | B-cell type acute leukaemia |
| 125285181 | 12528518 | 2 | B-cell type acute leukaemia |
| 125285181 | 12528518 | 3 | B-cell type acute leukaemia |
| 125285181 | 12528518 | 4 | B-cell type acute leukaemia |
| 125285181 | 12528518 | 5 | B-cell type acute leukaemia |
| 125285181 | 12528518 | 7 | Back pain |
| 125285181 | 12528518 | 9 | Back pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125285181 | 12528518 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125285181 | 12528518 | B-cell type acute leukaemia | |
| 125285181 | 12528518 | Blood glucose increased | |
| 125285181 | 12528518 | Coagulopathy | |
| 125285181 | 12528518 | Disease recurrence | |
| 125285181 | 12528518 | Jaundice | |
| 125285181 | 12528518 | Meningitis bacterial | |
| 125285181 | 12528518 | Nausea | |
| 125285181 | 12528518 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125285181 | 12528518 | 1 | 20150930 | 0 | ||
| 125285181 | 12528518 | 2 | 20150930 | 0 | ||
| 125285181 | 12528518 | 3 | 20150930 | 0 | ||
| 125285181 | 12528518 | 4 | 20150930 | 0 | ||
| 125285181 | 12528518 | 5 | 20150501 | 20150801 | 0 | |
| 125285181 | 12528518 | 6 | 20150918 | 0 | ||
| 125285181 | 12528518 | 7 | 20150901 | 0 | ||
| 125285181 | 12528518 | 8 | 20150918 | 0 | ||
| 125285181 | 12528518 | 9 | 20150914 | 0 |